Mohamed-Bilal Fares

α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer

Bruno Fauvet, Martial Mbefo, Mohamed-Bilal Fares et al. · Journal of Biological Chemistry · 2012 · 568 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +10

The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of  -synuclein, and enhances its secretion and nuclear localization in cells

Mohamed-Bilal Fares, Nadine Ait‐Bouziad, Igor Dikiy et al. · Human Molecular Genetics · 2014 · 236 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Characterization of Semisynthetic and Naturally Nα-Acetylated α-Synuclein in Vitro and in Intact Cells

Bruno Fauvet, Mohamed-Bilal Fares, Filsy Samuel et al. · Journal of Biological Chemistry · 2012 · 173 citations · Full text

Life Sciences, Biochemistry, Neuroscience +10

Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson’s disease

Mohamed-Bilal Fares, Bohumil Maco, Abid Oueslati et al. · Proceedings of the National Academy of Sciences · 2016 · 117 citations · Full text

Life Sciences, Neurology, Neuroscience +16

N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting

Sean M. DeGuire, Francesco Simone Ruggeri, Mohamed-Bilal Fares et al. · Journal of Biological Chemistry · 2018 · 89 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12